NO20030523L - Polymorfer av zaleplon og fremgangsmater for fremstillingen derav - Google Patents

Polymorfer av zaleplon og fremgangsmater for fremstillingen derav

Info

Publication number
NO20030523L
NO20030523L NO20030523A NO20030523A NO20030523L NO 20030523 L NO20030523 L NO 20030523L NO 20030523 A NO20030523 A NO 20030523A NO 20030523 A NO20030523 A NO 20030523A NO 20030523 L NO20030523 L NO 20030523L
Authority
NO
Norway
Prior art keywords
zaleplon
polymorphs
processes
preparation
Prior art date
Application number
NO20030523A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030523D0 (no
Inventor
Farhan Aslam
Brett Cowans
Stephen Robert Byrn
G Patrick Stahly
Original Assignee
Meda Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Ab filed Critical Meda Ab
Publication of NO20030523D0 publication Critical patent/NO20030523D0/no
Publication of NO20030523L publication Critical patent/NO20030523L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20030523A 2000-08-03 2003-02-03 Polymorfer av zaleplon og fremgangsmater for fremstillingen derav NO20030523L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22278500P 2000-08-03 2000-08-03
PCT/US2001/024510 WO2002012244A2 (en) 2000-08-03 2001-08-02 Polymorphs of zaleplon and methods for the preparation thereof

Publications (2)

Publication Number Publication Date
NO20030523D0 NO20030523D0 (no) 2003-02-03
NO20030523L true NO20030523L (no) 2003-03-11

Family

ID=22833666

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030523A NO20030523L (no) 2000-08-03 2003-02-03 Polymorfer av zaleplon og fremgangsmater for fremstillingen derav

Country Status (18)

Country Link
US (2) US20020072527A1 (xx)
EP (1) EP1305315A2 (xx)
JP (1) JP2004505979A (xx)
KR (2) KR20070086867A (xx)
CN (2) CN1847244A (xx)
AR (1) AR036324A1 (xx)
AU (2) AU8311901A (xx)
BR (1) BR0113244A (xx)
CA (1) CA2417875C (xx)
HU (1) HUP0303055A3 (xx)
IL (1) IL154088A0 (xx)
MX (1) MXPA03001048A (xx)
NO (1) NO20030523L (xx)
NZ (1) NZ527455A (xx)
PL (1) PL365678A1 (xx)
SG (1) SG125971A1 (xx)
WO (1) WO2002012244A2 (xx)
ZA (1) ZA200300779B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040007683A (ko) * 2001-06-12 2004-01-24 비오갈 기오기스제르갸르 알티. 잘레플론의 제조 방법
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
SK472004A3 (en) * 2001-08-01 2004-12-01 Biogal Gyogyszergyar Purification and crystalline forms of zaleplon
CN101426504A (zh) * 2002-02-15 2009-05-06 特瓦药厂私人有限公司 包含规定粒径分布的扎来普隆的粉末组合物和由其制得的药物制品
AU2002343201A1 (en) * 2002-10-16 2004-05-04 Sanmar Speciality Chemicals Limited Synthesis of zaleplon
WO2005023813A1 (en) * 2003-09-04 2005-03-17 Cipla Limited Zaleplon synthesis
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
US20100196286A1 (en) * 2008-12-01 2010-08-05 Armer Thomas A Inhalation delivery methods and devices
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
KR0167261B1 (ko) * 1995-10-19 1999-04-15 문정환 전원공급 제어회로
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
AR029780A1 (es) * 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
SK472004A3 (en) * 2001-08-01 2004-12-01 Biogal Gyogyszergyar Purification and crystalline forms of zaleplon

Also Published As

Publication number Publication date
EP1305315A2 (en) 2003-05-02
HUP0303055A3 (en) 2004-11-29
WO2002012244A3 (en) 2002-06-13
NZ527455A (en) 2005-07-29
AR036324A1 (es) 2004-09-01
US20050176735A1 (en) 2005-08-11
CN1610682A (zh) 2005-04-27
WO2002012244A2 (en) 2002-02-14
AU2001283119B2 (en) 2007-11-15
BR0113244A (pt) 2003-07-08
ZA200300779B (en) 2003-08-22
SG125971A1 (en) 2006-10-30
AU8311901A (en) 2002-02-18
MXPA03001048A (es) 2004-02-26
JP2004505979A (ja) 2004-02-26
US20020072527A1 (en) 2002-06-13
NO20030523D0 (no) 2003-02-03
CA2417875A1 (en) 2002-02-14
PL365678A1 (en) 2005-01-10
KR20070086867A (ko) 2007-08-27
CA2417875C (en) 2008-12-09
HUP0303055A2 (hu) 2004-01-28
KR20030036659A (ko) 2003-05-09
CN1847244A (zh) 2006-10-18
IL154088A0 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
NO20001648L (no) FremgangsmÕter og mellomprodukter for fremstilling av anti- cancerforbindelser
NO20044533D0 (no) Fremgangsmate for fremstilling av 7-substituerte 3-kinolin og 3-kinol-4-onkarbonitriler
NO20030707D0 (no) Polymorfer av en epothilon-analog
CY2013011I2 (el) Μεθοδος χορηγησης διφωσφονικων
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20021412L (no) Soyamelkeblandinger og fremgangsmåter for fremstilling
NO20022176D0 (no) Absorberende gjenstand og fremgangsmåte for fremstilling av denne
NO20032332L (no) Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20032403L (no) SiAION-holdig ytterbium og fremgangsmåte for fremstilling derav
DK1328538T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
NO20020622L (no) Polymorfer av torsemid
NO20030523D0 (no) Polymorfer av zaleplon og fremgangsmåter for fremstillingen derav
NO20021124D0 (no) Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20040887L (no) Rensing og krystallinske former av zaleplon.
NO20003555L (no) Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20024413D0 (no) Fremgangsmåte for tilvirkning og bruk av mikrogrupper av biologiske materialer
NO20024503L (no) FremgangsmÕte for tilveiebringelse av startkulturer med en konsistent kvalitet
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20033743L (no) Fremgangsmåte og fremstilling citalopram
EE200200410A (et) Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application